AGC Biologics Receives Transatlantic Award for Investments in Milan Biopharmaceutical Industry
Milan, Dec. 20, 2021 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it has won the 2021